Back to search

Article

FASN for diffuse malignant peritoneal mesothelioma: a prognostic biomarker after CRS+HIPEC and a therapeutic target

2026-02-16

Abstract excerpt

<title>Abstract</title> <p>Background Diffuse malignant peritoneal mesothelioma (DMPM) is a rare and aggressive malignancy with limited therapeutic options and poor clinical outcomes. While metabolic reprogramming, including altered lipid metabolism, is a recognized hallmark of cancer, its contribution to DMPM progression and treatment response remains poorly understood. Methods Gene expression profiling was pe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b5f3d671-f0f8-592f-86ff-1e009622b815
DOI
10.21203/rs.3.rs-8641233/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
FASN for diffuse malignant peritoneal mesothelioma: a prognostic biomarker after CRS+HIPEC and a therapeutic targetDOI 10.21203/rs.3.rs-8641233/v1
Select a neighboring publication to make it the new centre.